- Report
- September 2023
- 190 Pages
Global
From €3063EUR$3,185USD£2,627GBP
€4375EUR$4,550USD£3,753GBP
- Report
- February 2024
- 110 Pages
Global
From €4567EUR$4,750USD£3,918GBP
- Report
- February 2024
- 118 Pages
Global
From €4567EUR$4,750USD£3,918GBP
- Report
- January 2024
- 148 Pages
Global
From €4327EUR$4,500USD£3,712GBP
- Report
- March 2024
- 200 Pages
Global
From €3990EUR$4,150USD£3,423GBP
- Report
- January 2024
- 200 Pages
Global
From €3990EUR$4,150USD£3,423GBP
- Report
- March 2024
- 90 Pages
Middle East
From €5721EUR$5,950USD£4,908GBP
- Report
- November 2023
- 90 Pages
North America
From €2019EUR$2,100USD£1,732GBP
€2885EUR$3,000USD£2,475GBP
- Report
- November 2023
- 98 Pages
Asia Pacific
From €2019EUR$2,100USD£1,732GBP
€2885EUR$3,000USD£2,475GBP
- Report
- November 2023
- 99 Pages
Europe
From €2019EUR$2,100USD£1,732GBP
€2885EUR$3,000USD£2,475GBP
- Report
- November 2023
- 90 Pages
Middle East, Africa
From €2019EUR$2,100USD£1,732GBP
€2885EUR$3,000USD£2,475GBP
- Report
- November 2023
- 125 Pages
Middle East, Africa
From €2019EUR$2,100USD£1,732GBP
€2885EUR$3,000USD£2,475GBP
- Report
- September 2020
- 700 Pages
Global
From €4712EUR$4,900USD£4,042GBP
- Report
- January 2020
- 508 Pages
Global
From €4711EUR$4,899USD£4,041GBP
- Report
- August 2019
- 320 Pages
Global
From €4326EUR$4,499USD£3,711GBP
- Report
- March 2019
- 300 Pages
Global
From €4326EUR$4,499USD£3,711GBP
- Report
- July 2019
- 189 Pages
Global
From €1322EUR$1,375USD£1,134GBP
€2644EUR$2,750USD£2,268GBP
- Report
- June 2022
- 331 Pages
Global
From €4760EUR$4,950USD£4,083GBP
- Report
- December 2018
- 155 Pages
Global
From €817EUR$850USD£701GBP
- Report
- March 2023
- 139 Pages
Global
From €5288EUR$5,500USD£4,537GBP
The Adult Stem Cell market is a subset of the larger Stem Cell market, which is focused on the use of stem cells for medical treatments. Adult stem cells are found in the body and are used to replace or repair damaged tissue. These cells can be harvested from a patient's own body, or from a donor, and then used to treat a variety of conditions, including cancer, heart disease, and neurological disorders.
The Adult Stem Cell market is driven by the increasing demand for stem cell therapies, as well as the development of new technologies and techniques for harvesting and processing stem cells. Additionally, the market is supported by government funding and private investments.
Companies in the Adult Stem Cell market include Celgene Corporation, Osiris Therapeutics, Inc., Athersys, Inc., and Mesoblast Limited. Show Less Read more